Skip to main content

GDRX

GoodRx Holdings, Inc.

Company with tickers: GDRX

CIK
1809519
CUSIP
38246G108
Shares Outstanding
104,711,186
13F Activity (30d)
18 filings 3 filers

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Program Authorized
$450,000,000
as of 2024-02-27
Remaining Authorization
$60,200,000
as of 2026-03-31
Program Utilization
86.6% $389,800,000 used of $450,000,000

Cash spent on buybacks by quarter

Cash deployed each quarter, with the average price paid where the company reported it. Δ marks quarters derived from the company's cumulative year-to-date disclosures.

Repurchase History

Fiscal Year Ended Cash Spent
2026-03-31 YTD $12,567,000
2025-12-31 $216,372,000
2024-12-31 $158,845,000
2023-12-31 $103,974,000
2022-12-31 $101,721,000